logo
Housing Crisis 2025: Why Rental Shortages Could Spike Your Living Costs

Housing Crisis 2025: Why Rental Shortages Could Spike Your Living Costs

Yahoo2 days ago
According to a report by the National Low Income Housing Coalition, the U.S. has a shortage of 7.1 million rental units.
Be Aware:
Find Out:
That supply shortage has driven enormous rent spikes in recent years, with Consumer Affairs reporting that nationwide rents surged 23.4% between 2020 and 2022 alone. While rent growth has slowed over the last two years, it continues to drive up the cost of living in many cities.
Housing Disproportionately Drives Inflation
The Bureau of Labor Statistics combines the costs of many goods and services to calculate its consumer price index (CPI) inflation figure. But it weights those costs differently — and housing makes up about 35.5% of the total inflation rate.
So even if other costs, such as groceries, were going down in price (which they're not), fast rent growth could still cause high inflation rates.
Check Out:
Interest Rates Remaining Higher for Longer
The Federal Reserve started cutting interest rates in the second half of 2024, feeling confident that inflation was slowing. But the sudden appearance of tariffs caused it to fear heating inflation once again, and it's paused rate cuts to see how the economy responds to new tariffs.
'Since housing is a big part of the CPI, persistently high rents are keeping inflation stubbornly high,' explained Yancy Forsythe, founder of Missouri Valley Homes. 'That makes it harder for policymakers to ease rates.'
Higher interest rates make it more expensive for consumers to borrow and buy, and for businesses to borrow and expand by hiring. It puts a brake on the economy for both businesses and consumers.
Uneven Housing Shortages
Some cities have a surplus of rental housing. Austin, Texas, for example, has a high multifamily vacancy rate of 9.6%, according to Apartment List.
Others have dire shortages. Perennially difficult San Francisco has a vacancy rate of just 3.8%.
'With a rental vacancy rate of just 0.6% (a fraction of the 5% considered healthy), we're facing a critical shortfall of 23,500 units right now. This scarcity doesn't just hurt families — it puts pressure on wages, fuels inflation, and distorts our whole economy,' said Carla Gericke, who works as a real estate agent at Porcupine Real Estate in New Hampshire.
Even within individual cities, some neighborhoods have housing shortages while others have plenty of units available. A July study by Moody's Analytics found that most of the housing shortage appears in the lower- and middle-income neighborhoods, with housing surpluses in higher-income districts.
Red Tape for New Housing
Why do some cities have plenty of housing, while others continually struggle with affordability and availability?
Cities with abundant housing, such as Austin, Phoenix (7.9% multifamily vacancy rate) and Dallas (8.2%), encourage the construction of new housing supply. Other cities limit zoning of higher-density housing, and layer on regulations and fees that deter new housing development.
'The tightest rental markets right now are in coastal and high-income metros like San Francisco, Seattle, Boston, and San Diego where the supply constraints, zoning restrictions and booming demand have created rent spikes and ultra low vacancy rates,' Forsythe said. 'In San Francisco for example, rents rose by more than 11% year-over-year, while rental vacancy rates have dropped to half the national average.'
Affordable housing shortages will likely keep fueling inflation, slowing interest rate cuts and pinching lower-income families until there's more of it.
More From GOBankingRates
6 Big Shakeups Coming to Social Security in 2025
This article originally appeared on GOBankingRates.com: Housing Crisis 2025: Why Rental Shortages Could Spike Your Living Costs
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

FuboTV Delivers Surprise Profit, Hulu + Live TV Merger Plans Advance
FuboTV Delivers Surprise Profit, Hulu + Live TV Merger Plans Advance

Yahoo

time25 minutes ago

  • Yahoo

FuboTV Delivers Surprise Profit, Hulu + Live TV Merger Plans Advance

FuboTV (NYSE:FUBO) stock gained on Friday after it reported earnings for the second quarter of 2025, but it has since reversed those gains and is now trading lower by 1%. Revenue of the sports-first live TV streaming platform declined 2.8% year-over-year (Y/Y) to $379.97 million, topping the analyst consensus estimate of $353.77 million. Adjusted EPS of 5 cents beat the analyst consensus of a one-cent loss. The company's adjusted EBITDA margin stood at 5.4% versus (2.8)% Y/ America Streaming revenue fell 3% year-over-year to $371.3 million. Paid subscribers also saw a decline, decreasing by 6.5% year-over-year to 1.36 million. Despite this drop, the subscriber count still managed to exceed the company's preliminary estimates. In the Rest of World, revenue was $8.7 million, a 4.7% Y/Y growth, and paid subscribers declined 12.5% Y/Y to 349,000. As of June 30, FuboTV held $289.7 million in cash and equivalents. The company used $(37.7) million in free cash flow in the quarter, compared to $(35.3) million from a year ago. View more earnings on FUBO Fubo filed a preliminary proxy statement seeking shareholder approval for its agreement with The Walt Disney Co. (NYSE:DIS) to combine Fubo with Hulu + Live TV, targeting a closing in late 2025 or early 2026 pending regulatory and shareholder approvals. The company remains committed to offering consumers diverse content at competitive prices, launching Fubo Sports in the coming weeks and introducing a Pay-Per-View option for both subscribers and non-subscribers. Fubo continued investing in product and user experience, rolling out features like Catch Up to Live, Game Highlights, and Timeline Markers. It also diversified its content portfolio and expanded partnerships to enhance subscriber value. 'The second quarter of 2025 marked a pivotal milestone in Fubo's business,' said David Gandler, co-founder and CEO of Fubo. 'Our continued focus on delivering choice and flexibility to consumers positions us well to capitalize on emerging opportunities as the traditional content landscape continues to evolve.' 'We are pleased with our second quarter results including top-line outperformance,' said Edgar Bronfman Jr., executive chairman of Fubo. 'We continue to innovate our sports entertainment streaming platform striving for unparalleled product quality and a frictionless content experience, and look forward to keeping shareholders updated on our progress.' Fubo stock gained 194% year-to-date. Price Action: Fubo stock is trading lower by 1.08% to $3.660 at last check Friday. Photo via Shutterstock UNLOCKED: 5 NEW TRADES EVERY WEEK. Click now to get top trade ideas daily, plus unlimited access to cutting-edge tools and strategies to gain an edge in the markets. Get the latest stock analysis from Benzinga? This article FuboTV Delivers Surprise Profit, Hulu + Live TV Merger Plans Advance originally appeared on © 2025 Benzinga does not provide investment advice. All rights reserved. Sign in to access your portfolio

Baculovirus Expression System Market Poised for Significant Growth, Estimate to Hit USD 781.8 Million by 2032
Baculovirus Expression System Market Poised for Significant Growth, Estimate to Hit USD 781.8 Million by 2032

Yahoo

time25 minutes ago

  • Yahoo

Baculovirus Expression System Market Poised for Significant Growth, Estimate to Hit USD 781.8 Million by 2032

Burlingame, CA, Aug. 08, 2025 (GLOBE NEWSWIRE) -- The global Baculovirus Expression System Market is estimated to be valued at USD 436.0 Mn in 2025 and is expected to reach USD 781.8 Mn in 2032, exhibiting a compound annual growth rate (CAGR) of 8.7% from 2025 to 2032. The baculovirus expression system market is expanding steadily, driven by its growing use in producing recombinant proteins, vaccines, and gene therapy vectors due to its high expression efficiency and scalability. Rising demand for advanced biologics, increasing investment in vaccine development, and the surge in research for novel therapeutics are fueling market growth. Technological advancements, such as improved vector design and enhanced expression yields, are creating new opportunities for biopharmaceutical manufacturing. With expanding applications in cancer research, infectious disease treatment, and personalized medicine, the baculovirus expression system market offers significant demand opportunities in both research and commercial bioproduction sectors. Request Sample Copy: Global Baculovirus Expression System Market Key Takeaways According to Coherent Market Insights (CMI), the global baculovirus expression system market size is expected to reach USD 781.8 Mn by 2032, up from USD 436 Mn in 2025, registering a CAGR of 8.7%. Therapeutics remain the most lucrative application for baculovirus expression systems, accounting for 38% of the global market share in 2025. North America is set to dominate the industry, accounting for more than one-third of the global baculovirus expression system market share in 2025. Europe, with an estimated share of over one-fourth in 2025, is expected to remain the second-largest market for baculovirus expression system companies. Asia Pacific market is poised to record the fastest growth during the assessment period. Soaring Demand for Recombinant Proteins Propelling Market Growth Coherent Market Insights' latest baculovirus expression system market research report lists major factors driving industry growth. Increasing demand for recombinant proteins is one such growth driver. Recombinant proteins are witnessing high demand due to their broad application in therapeutic development, vaccine production, and biomedical research. They are becoming essential in drug discovery and disease treatment due to their ability to mimic natural proteins with high precision. Baculovirus expression systems (BES) are especially valued for their efficiency in producing complex recombinant proteins, especially eukaryotic proteins. As the demand for these sophisticated proteins rises, the need for advanced expression systems like baculovirus is expected to grow correspondingly, driving market growth. Purchase Now Up to 25% Discount on This Premium Report: High Production Costs and Adoption of Alternatives Hampering Market Growth The prospective baculovirus expression system market outlook looks promising, owing to rising demand for recombinant proteins. However, high production costs and competition for alternative expression systems present a significant barrier to widespread market expansion. Baculovirus expression system involves complex production processes and specialized infrastructure, leading to high operational costs. These factors limit its adoption and dampen overall baculovirus expression system market demand. Moreover, many pharmaceutical and biopharmaceutical companies opt for alternative expression systems like CHO cells, yeast, and E. coli as they are more established and cost-effective. This trend may further hinder baculovirus expression system market growth during the forecast period. Expanding Biopharmaceutical Industry Creating Lucrative Growth Opportunities The global biopharmaceutical sector is thriving as the need for vaccines, biologics, and gene therapies continues to rise. This trend is fueling demand for efficient and scalable expression systems like baculovirus, which are instrumental in recombinant protein production. As a result, significant growth opportunities are emerging for companies operating in this space. \Impact of AI on the Baculovirus Expression System Market Artificial Intelligence (AI) is positively impacting the baculovirus expression system (BEVS) market. It not only streamlines protein production processes but also improves overall efficiency. Researchers can optimize variables like cell density, media composition, and viral vector design by using AI-driven modeling and predictive analytics. These optimizations can lead to improved protein yields and faster development timelines. AI also supports real-time monitoring and automation in bioreactors, thereby reducing the need for manual intervention and minimizing contamination risks. These advancements are particularly valuable in the production of vaccines, gene therapies, and complex recombinant proteins. Advanced technologies like AI are making BEVS more scalable and cost-effective. They are accelerating its adoption across pharmaceutical and biotechnology sectors, thereby supporting expansion of the baculovirus expression system industry. Emerging Baculovirus Expression System Market Trends Rising preference for baculovirus expression systems in biopharmaceutical production and vaccine development is a key growth-shaping trend. Baculovirus systems are particularly valued for their scalability, safety, and ability to produce complex proteins, including virus-like particles (VLPs) and subunit vaccines (e.g., for COVID-19). Increasing demand for gene and cell therapies is driving interest in baculovirus expression systems. Baculovirus vectors are being investigated for gene delivery applications and show potential in the development of engineered cell therapies, including experimental CAR-T platforms. Growing trend of outsourcing is positively influencing the baculovirus expression system market value. Biotech and pharmaceutical companies are increasingly partnering with CDMOs that specialize in baculovirus-based protein production to streamline operations and reduce costs. Escalating demand for biosimilars is driving interest in alternative expression platforms, including baculovirus expression systems. These systems are used by pharmaceutical and biopharmaceutical companies for the efficient and cost-effective production of certain biosimilar proteins, particularly where complex mammalian glycosylation is not essential. Advancements in genetic engineering and biotechnology are further boosting market growth. Recent innovations like improved baculovirus vectors, optimized host cell lines, and refined expression technologies have significantly enhanced recombinant protein yield and quality. Similarly, gene-editing tools like CRISPR are being explored to modify host cells or viral genomes, expanding the potential of baculovirus systems in research and biopharmaceutical production. Request For Customization: Analyst's View said senior analyst Abhijeet Kale. Current Events and Their Impact on the Baculovirus Expression System Market Event Description and Impact Emerging RSV and Influenza Vaccine Pipelines (2024–2025) Description: Biopharma companies like Novavax and Sanofi are expanding their recombinant protein-based vaccine pipelines post-COVID, especially for RSV and influenza. Impact: This leads to increased reliance on baculovirus platforms for scalable antigen production due to their proven safety, rapid expression timeline, and cost-effectiveness. Novavax's use of BEVS (baculovirus expression vector system) for its RSV vaccine further validates this trend. CRISPR and Gene Editing Advancements in Insect Cell Lines Description: Enhanced cell lines like Sf9 and Hi5 are being engineered using CRISPR to increase yield and stability of expressed proteins. Impact: These improvements are reducing production costs and turnaround time, making baculovirus systems more competitive for monoclonal antibody and enzyme production. AI in Biomanufacturing (2024) Description: Companies are applying AI to optimize expression parameters in insect cell cultures. Impact: AI-driven process development is improving consistency and yield in baculovirus-based manufacturing, making them more attractive for precision biologics and personalized therapies. Competitor InsightsKey companies in baculovirus expression system market report: Merck KGaA Thermo Fisher Scientific Takara Bio Oxford Expression Technologies Qiagen N.V. Agilent Technologies Bio-Rad Laboratories Promega Corporation New England Biolabs Syngene International Limited Sartorius AG Genscript Biotech Corporation Absolute Antibody Creative Biogene Aragen Bioscience Vivopure Rockland Immunochemicals Virovek Proteogenix Protein Technologies, Inc. (PTI) Key Developments In April 2025, Qiagen expanded its digital PCR portfolio with the launch of new Lentivirus solutions to strengthen gene and cell therapy quality control. This highlights the company's commitment to help accelerate the development of safe and effective biotherapeutics. In April 2024, Expression Systems collaborated with Thomson to demonstrate how the combination of its ESF AdvanCD™ cell culture medium and Thomson Optimum Growth® flasks offers an effective solution for scaling up protein production using baculovirus and insect cell expression systems. Global Baculovirus Expression System Market Segmentation: By Product TypeBaculovirusExpression VectorReagentsOthersBy ApplicationTherapeuticsVaccinesProtein PurificationOthersBy End UserBiopharmaceutical CompaniesResearch InstitutesOthersBy RegionNorth AmericaEuropeAsia PacificLatin AmericaMiddle East & AfricaRead More ReportsCell-Free Protein Expression Market Size, Share & Trend Analysis Report for 2025-2032Recombinant Protein Market Analysis and Forecast for 2025-2032Protein Expression Systems Market Size, Share, Trends & Opportunities for 2025-2032 Our Trusted Partners:Worldwide Market Reports, Coherent MI, Stratagem Market InsightsGet Recent News: CONTACT: About Us: Coherent Market Insights leads into data and analytics, audience measurement, consumer behaviors, and market trend analysis. From shorter dispatch to in-depth insights, CMI has exceled in offering research, analytics, and consumer-focused shifts for nearly a decade. With cutting-edge syndicated tools and custom-made research services, we empower businesses to move in the direction of growth. We are multifunctional in our work scope and have 450+ seasoned consultants, analysts, and researchers across 26+ industries spread out in 32+ countries. Contact Us: Mr. Shah Coherent Market Insights 533 Airport Boulevard, Suite 400, Burlingame, CA 94010, United States US: + 12524771362 UK: +442039578553 AUS: +61-2-4786-0457 India: +91-848-285-0837 Email: sales@ Website: For Latest Update Follow Us: LinkedIn | Facebook | TwitterError in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Portland General Electric brings 475MW of battery storage online
Portland General Electric brings 475MW of battery storage online

Yahoo

time25 minutes ago

  • Yahoo

Portland General Electric brings 475MW of battery storage online

Portland General Electric (PGE) has energised 475MW of battery energy storage to boost grid reliability and keep costs low for customers in the US state of Oregon. The three new utility-scale battery energy storage systems add more than 1.9 gigawatt hours (GWh) of dispatchable capacity, bolstering the electricity supply for the Portland metro area. Collectively, these installations will power 300,000 homes for up to four hours during peak demand. The lithium-ion energy storage systems are situated at key substations in North Portland, Troutdale and Hillsboro. They are designed to optimise the balance between electricity production with consumption more effectively, alleviating pressure on the grid. The integration of battery storage technology not only diminishes its dependence on costly short-term electricity purchases but also contributes to stabilising energy costs and mitigating price fluctuations for consumers. These systems also facilitate the incorporation of renewable energy sources, such as wind and solar. Two of the newly operational facilities were developed by Eolian, as part of PGE's 2021 All-Source Request for Proposals (RFP) process. Located in North Portland, the 200MW Seaside facility was delivered to PGE by Eolian under a fixed-cost build-to-transfer agreement. Commercial operations were started in July 2025. The Sundial, a 200MW facility in Troutdale, was developed by Eolian and will be operated under a 20-year storage capacity agreement by NextEra Energy Resources. It began operations in December 2024. The third facility, Constable, is a 75MW installation owned by PGE in Hillsboro, constructed under an engineering, procurement and construction (EPC) agreement with Mortenson that reached commercial operation in December 2024. PGE also completed its Coffee Creek battery storage system near Wilsonville in 2024, bringing its total large-scale battery storage capacity up to 492MW. In December, the company made a power purchase agreement (PPA) with Avangrid to procure electricity from the Tower solar project, in Portland, Oregon, which has a capacity of 120 megawatts alternating current (166 megawatts direct current). "Portland General Electric brings 475MW of battery storage online" was originally created and published by Power Technology, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store